FUNCTION OF THE TRANSCRIPTIONAL REGULATING PROTEIN OF 132 kDa (TReP-132) ON HUMAN P450scc GENE EXPRESSION
暂无分享,去创建一个
D. Hum | B. Staels | B. Beatty | F. Dewitte | M. El‐Alfy | F. Gizard | B. Lavallée | Y. Duguay
[1] D. Hum,et al. The Transcriptional Regulating Protein of 132 kDa (TReP-132) Enhances P450scc Gene Transcription through Interaction with Steroidogenic Factor-1 in Human Adrenal Cells* , 2002, The Journal of Biological Chemistry.
[2] Y. Labrie,et al. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. , 2002, Cancer research.
[3] D. Hum,et al. A Novel Zinc Finger Protein TReP-132 Interacts with CBP/p300 to Regulate Human CYP11A1 Gene Expression* , 2001, The Journal of Biological Chemistry.
[4] M. C. Hu,et al. Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. , 2001, Molecular endocrinology.
[5] H. Dyson,et al. Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Miller,et al. Cloning of Factors Related to HIV-inducible LBP Proteins That Regulate Steroidogenic Factor-1-independent Human Placental Transcription of the Cholesterol Side-chain Cleavage Enzyme, P450scc* , 2000, The Journal of Biological Chemistry.
[7] W. Jiang,et al. Identification and localization of MEP1A-like sequences (MEP1AL1-4) in the human genome. , 1999, Biochemical and biophysical research communications.
[8] I. Pikuleva,et al. Cytochromes P450 in synthesis of steroid hormones, bile acids, vitamin D3 and cholesterol. , 1999, Molecular aspects of medicine.
[9] A. Lamond,et al. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. , 1998, Genes & development.
[10] G. Hammer,et al. Wilms' Tumor 1 and Dax-1 Modulate the Orphan Nuclear Receptor SF-1 in Sex-Specific Gene Expression , 1998, Cell.
[11] D. Monté,et al. Regulation of the Human P450scc Gene by Steroidogenic Factor 1 Is Mediated by CBP/p300* , 1998, The Journal of Biological Chemistry.
[12] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[13] B. Schimmer,et al. Steroidogenic factor 1: a key determinant of endocrine development and function. , 1997, Endocrine reviews.
[14] G. Chrousos,et al. Steroidogenic factor 1 messenger ribonucleic acid expression in steroidogenic and nonsteroidogenic human tissues: Northern blot and in situ hybridization studies. , 1997, The Journal of clinical endocrinology and metabolism.
[15] M. Ito,et al. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita , 1997, Molecular and cellular biology.
[16] D. Hum,et al. Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. , 1997, The Journal of clinical endocrinology and metabolism.
[17] T. Gibson,et al. The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. , 1996, Trends in biochemical sciences.
[18] J. Milbrandt,et al. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[19] K. Morohashi,et al. Function and distribution of a steroidogenic cell-specific transcription factor, Ad4BP , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[20] K. Miyagawa,et al. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing , 1995, Cell.
[21] P. Aza-Blanc,et al. Characterization of placental transcriptional activation of the human gene for P450scc. , 1995, DNA and cell biology.
[22] W. Herr,et al. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription , 1994, Molecular and cellular biology.
[23] M. Green,et al. DNA-binding domains: targets for viral and cellular regulators. , 1994, Current opinion in cell biology.
[24] S. Honda,et al. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. , 1993, The Journal of biological chemistry.
[25] D. Hum,et al. Identification of positive and negative placenta-specific basal elements and a cyclic adenosine 3',5'-monophosphate response element in the human gene for P450scc. , 1992, Molecular endocrinology.
[26] K. Parker,et al. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. , 1992, Molecular endocrinology.
[27] W. Bickmore,et al. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. , 1992, Science.
[28] T. Unger,et al. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. , 1992, The EMBO journal.
[29] W. Herr,et al. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter , 1992, Cell.
[30] K. Parker,et al. A shared promoter element regulates the expression of three steroidogenic enzymes. , 1991, Molecular endocrinology.
[31] T. Curran,et al. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. , 1990, Science.
[32] E. A. O'neill,et al. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain , 1989, Cell.
[33] R. Tjian,et al. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.
[34] A. E. Sippel,et al. Viral myb oncogene encodes a sequence-specific DNA-binding activity , 1988, Nature.
[35] A. E. Sippel,et al. The highly conserved amino‐terminal region of the protein encoded by the v‐myb oncogene functions as a DNA‐binding domain. , 1987, The EMBO journal.
[36] M. Waterman,et al. Control of gene expression of adrenal steroid hydroxylases and related enzymes. , 1986, Endocrine research.